8-K
Current Report
Tempest Therapeutics, Inc. Filed Acc 0001104659-17-040651
Exit or restructuring costs · Executive or director change · Other events
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading a17-15543_18k.htm…